BGXX vs. MDWD, FTLF, NAII, MTEX, UPXI, PAVS, HAPP, IMCC, BON, and AKAN
Should you be buying Bright Green stock or one of its competitors? The main competitors of Bright Green include MediWound (MDWD), FitLife Brands (FTLF), Natural Alternatives International (NAII), Mannatech (MTEX), Upexi (UPXI), Paranovus Entertainment Technology (PAVS), Happiness Development Group (HAPP), IM Cannabis (IMCC), Bon Natural Life (BON), and Akanda (AKAN). These companies are all part of the "medicinals & botanicals" industry.
Bright Green (NASDAQ:BGXX) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, community ranking, earnings, dividends and profitability.
MediWound received 389 more outperform votes than Bright Green when rated by MarketBeat users.
Bright Green has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500.
7.8% of Bright Green shares are owned by institutional investors. Comparatively, 46.8% of MediWound shares are owned by institutional investors. 51.4% of Bright Green shares are owned by insiders. Comparatively, 9.2% of MediWound shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
MediWound has higher revenue and earnings than Bright Green. MediWound is trading at a lower price-to-earnings ratio than Bright Green, indicating that it is currently the more affordable of the two stocks.
MediWound has a consensus price target of $32.00, suggesting a potential upside of 96.20%. Given MediWound's higher probable upside, analysts plainly believe MediWound is more favorable than Bright Green.
Bright Green has a net margin of 0.00% compared to MediWound's net margin of -64.24%. MediWound's return on equity of -21.67% beat Bright Green's return on equity.
In the previous week, MediWound had 7 more articles in the media than Bright Green. MarketBeat recorded 10 mentions for MediWound and 3 mentions for Bright Green. MediWound's average media sentiment score of 0.47 beat Bright Green's score of 0.31 indicating that MediWound is being referred to more favorably in the news media.
Summary
MediWound beats Bright Green on 11 of the 15 factors compared between the two stocks.
Get Bright Green News Delivered to You Automatically
Sign up to receive the latest news and ratings for BGXX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BGXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bright Green Competitors List
Related Companies and Tools
